Position in SILO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$469,364
+$230,337 QoQ
Shares Held
75,582
+70.8% QoQ
Ownership
4.76%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1
of 9 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SILO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $30,987,010 across 21 Biotechnology names. SILO ranks #16 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
121,381 | $5,709,762 | |
| 2 | 882,892 | $4,652,840 | |||
| 3 | RLMD |
Relmada Therapeutics, Inc.
|
438,901 | $3,037,194 | |
| 4 | NRXP |
NRX Pharmaceuticals, Inc.
|
659,018 | $2,695,383 | |
| 5 | HELP |
Helus Pharma Inc.
|
292,711 | $1,934,819 | |
| 6 | GHRS |
GH Research PLC
|
71,267 | $1,915,656 | |
| 7 | ANRO |
Alto Neuroscience, Inc.
|
70,748 | $1,867,039 | |
| 8 | DRUG |
Bright Minds Biosciences Inc.
|
24,274 | $1,704,034 |
All Filings in SILO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $469,364 | 75,582 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $239,027 | 663,965 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $203,832 | 599,507 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $251,765 | 364,878 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $116,068 | 184,236 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $145,356 | 124,236 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||